drugset / Trial / NCT06585852

Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid (RGD) in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement

NCT06585852

Recruiting 18 enrolled Al-Azhar University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid (RGD) , in horizontal ridge augmentation with split-crest technique, for implant placement.

Timeline

Start
2023-08-01
Primary completion
2024-09-01
Completion
2024-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject RGD Unknown
Background Xenograft Other / unclassified

Indications

No indication recorded.